transport of sodium; permeability to water; cyclic nucleotide phosphodiesterase IT IS WELL ESTABLISHED that the sodium transport and the water permeability responses of the toad urinary bladder to vasopressin are mediated by the elevated concentration of intracellular cyclic AMP that results from stimulation of adenylate cyclase activity by the hormone (8, 18, 19) . Indirect evidence gathered in many tissues indicates that prostaglandins affect adenylate cyclase activity (1 O), and in the toad bladder they inhibit the adenylate cyclase response to vasopressin (4, 13, 20) . In view of this inhibitory effect, it has been suggested (7) that endogenous prostaglandins act as modulators of the response to vasopressin. In this study, the effect of indomethacin, an inhibitor of prostaglandin synthesis (5, 25) , and the efiect of polyphloretin phosphate, a prostaglandin antagonist (2, 3), were examined in order to elucidate the role of endogenous prostaglandins in the toad bladder response to vasopressin. The results, in part confirming those of others (6, 21) , are such that the effects of these agents cannot be attributed solely to altered activity of endogenous prostaglandins. In addition, in contrast to an earlier report (13), it was found that PGEl inhibits the short-circuit current (SCC) response to vasopressin as well as the water permeability response to vasopressin.
METHODS
In each series of experiments, Rufo marinus of one geographic origin, either Colombia (The Pet Farm, Miami, Fla.) or the Dominican Republic (National Reagents, Bridgeport, Conn.) were used. Urinary bladders were dissected from doubly pithed toads that had been kept in the laboratory on damp San-i-tel. The bladders were mounted on double chambers (17, 23) for measurement of shortcircuit current (24) or were mounted as sacs on glass tubes held in rubber stoppers for measurement of water permeability (1). Approximately 30 min after mounting, mucosal and serosal solutions were changed and observations were begun.
In the short-circuit current studies, bladders were discarded if the electric potential difference was less than 10 mV. Short-circuit current was measured every 10 min until a stable (< 10% change in 30 min) SCC was obtained. Prostaglandin El (PGEI), indomethacin, or polyphloretin phosphate (PPP) was added to the serosal solution of the experimental bladder, an equal volume of diluent was added to the serosal solution of the control tissue, and SCC was observed for 40 min. Vasopressin or cyclic AMP, in concentrations that elicit a submaximal response, was then added to the serosal solution of control and experimental preparations, and SCC was recorded every 5 min for 40 min. In order to be certain that the response was submaximal, at the end of the experiment, Pitressin, 50 mu/ml, was added to both serosal solutions, and SCC was recorded every 3 min until a peak was reached. Experiments were discarded if the peak XC elicited by Pitressin, 50 mU/ml, did not exceed the previous submaximal peak response by at least 10 %. The results of each short-circuit current experiment are normalized for the base-line SCC of each area of tissue, i.e., (change in response to agent) X 100,' (SCC before any additions).
In Although the data for each series of experiments were gathered within a period of less than 2 wk, the study itself was carried out over a period of 18 mo. Difierences in the response to the same agents in different series may be the result of seasonal factors. For example, in Table  4 , series A was performed 6 mo earlier than sarias B and C; series D, 8 mo before series E, series F 7 mo before series G; and series 1 6 mo before series J. PGEl had no effect on the SCC response to cyclic AMP (Table  1) . Inhibition of the response to vasopressin was evident regardless of whether bladders were incubated with PGEl for 30 min before vasopressin was added or the two agents were added simultaneously. Lipson and Sharp (13) (-11 & 1.7 , normalized mean A h SE, 12 = 5), and had no effect on SCC in a concentration of 0.7 PM (-5.0 + 6.8, n = 7) or lower. Although a low concentration of indomethacin enhanced the SCC response to vasopressin in two series (A and B, Table 2), it had no effect in a third series of experiments (C, Table 2 ) and did not alter the SCC response to cyclic AMP (D, Table  2 ). These results with indomethacin differ from those observed in experiments concerning the water permeability response to vasopressin and to cyclic AMP.
MATERIALS
As expected (4, 13, 20, 26) , exogenous PGEl inhibited the water permeability response to vasopressin. In 11 paired experiments, the submaximal control response to vasopressin was 10.2 mg/min and was 2.7 =t 0.4 mg/min (mean & SE, 1' < .OOl) lower in paired sacs incubated with vasopressin plus 2.5 X 10Bg M PGEr. Indomethacin alone had no effect on water permeability and clearly enhanced the response to vasopressin (A and B, Table  3 ) and to cyclic AMP (E ,  Table 3 ). Flores and Sharp (6) Table 4 ) and did not stimulate the response to cyclic AMP (I and J, Table 4 ). Ozer and Sharp (21) have reported that PPP enhances the submaximal water permeability response to vasopressin in the presence or absence of PGEI . In contrast to the enhancement of the effect of cyclic AMP in experiment F and G in Table 4 , they found no effect on the response to dibutyryl cyclic AMP, using a diRerent protocol (21). The latter experiments of Ozer and Sharp were repeated and in four series, results similar to theirs (21) were obtained, i.e., the response to dibutyryl cyclic AMP was not altered by PPP (experiments A-D, Table  5 Whatever the mechanism of the enhancement of the response to exogenous cyclic AMP, a similar mechanism presumably contributes to the enhancement by these agents of the response to vasopressin.
The latter enhancement therefore cannot be attributed solely to inhibition of the synthesis or of the effect of endogenous prostaglandins in the toad bladder.
Explanation of the action of indomethacin and PPP is made difficult by the effect of these agents in the presence of exogenous PGEI. Indomethacin has no effect on the response to vasopressin in the presence of PGEI , but the enhancement of the response to cyclic AMP is not altered by the presence of PGEI (Table 3) . PPP inhibits the response to vasopressin in the presence of PGEI and has no effect on the response to cyclic AMP in the presence of PGEI . These effects are not explained by indomethacin or PPP acting as a PGEI antagonist at the point of aden ylate cyclase either agent acting as estera se in hibitor , It is appropriate to note that another agent that stimula tes the water permeability response to vasopressin, chlorpropamide (11, 16) , inhibits the response to vasopressin in the presence of PG& (14) 
